Abstract
Background
Canine otitis externa provides a chronic, inflamed and frequently antimicrobial-exposed niche in which Pseudomonas aeruginosa can persist through a coordinated repertoire of adhesion, biofilm, iron-acquisition, secretion and toxin systems.
Methods
We characterized the virulence-associated genomic architecture of a historical Hungarian collection obtained from canine otitis cases in 2010 and 2017. Of the 70 isolate identifiers in the nominal range 70–139, 60 had corresponding long-read assemblies and linked VFDB screening records. One assembly was excluded after genome-based taxonomic validation showed that it did not meet the species-level criterion for P. aeruginosa.
Results
Primary absence-sensitive analyses were restricted to 52 genome-confirmed P. aeruginosa assemblies meeting prespecified CheckM criteria (completeness ≥95%, contamination ≤5%), while seven additional genome-confirmed P. aeruginosa assemblies that did not meet the primary CheckM criteria were retained only for descriptive contextualization and were excluded from prevalence denominators and absence-sensitive analyses. The primary cohort contained 242 distinct virulence-associated genes, with a median of 230.5 genes per isolate. Of these, 217 (89.7%) were core-like, occurring in at least 95% of genomes. Alginate, type IV pilus, flagellar, siderophore, phenazine, quorum-sensing, type II, type III and type VI secretion backbones were broadly conserved. In contrast, type III effector content was heterogeneous: exoT occurred in 52/52 isolates, exoY in 50/52, exoS in 49/52 and exoU in 4/52; one isolate showed assembly-level co-detection of exoS and an exoU-homologous sequence. Whole-virulome composition did not differ detectably between 2010 and 2017 (square-root Jaccard PERMANOVA, R2 = 0.0134, p = 0.6083), and no individual gene remained associated with collection year after false-discovery-rate correction.
Conclusion
These data define a conserved historical virulence-associated genomic backbone punctuated by isolate-level effector and surface-structure variation. The detected genes are interpreted as genomic homologues and repertoire features rather than as evidence of their expression or functional contribution to pathogenicity.
Keywords: canine otitis externa, exos, ExoU, one health, Pseudomonas aeruginosa, type III secretion system, virulome, whole-genome sequencing
1. Introduction
Canine otitis externa is among the most frequent disorders encountered in small-animal practice, with population-level studies estimating that approximately 7–10% of dogs receive this diagnosis in primary care (1). The condition is not a single infectious entity but a multifactorial inflammatory syndrome in which primary disease, anatomical predisposition and perpetuating pathological changes alter the external ear canal and permit secondary microbial overgrowth (1, 2). Among bacterial agents, Pseudomonas aeruginosa is particularly important in chronic, recurrent and treatment-refractory disease because it combines environmental persistence, broad metabolic adaptability, intrinsic antimicrobial resistance, rapid acquisition of additional resistance and a strong capacity for biofilm-associated growth (2–8).
The clinical challenge posed by P. aeruginosa cannot be explained by antimicrobial resistance alone. Successful colonization and persistence require coordinated attachment, motility, acquisition of limiting nutrients, evasion or manipulation of host responses and damage to epithelial tissues. The organism therefore deploys a multilayered virulence repertoire that includes flagella and type IV pili, lipopolysaccharide, alginate and other extracellular polysaccharides, pyoverdine and pyochelin siderophores, quorum-sensing networks, phenazines, rhamnolipids, extracellular proteases and phospholipases, exotoxin A and multiple secretion systems (9–15). These determinants operate as an interconnected architecture rather than as independent markers: quorum sensing regulates secreted enzymes and exoproducts, biofilm matrices alter spatial organization and stress tolerance, siderophores support growth under iron limitation, and secretion systems mediate both host-cell manipulation and interbacterial competition (9, 16, 17). Quorum sensing is particularly relevant in this context because it coordinates population-level responses, biofilm-associated behavior, stress adaptation and collective responses to antimicrobial exposure, thereby linking virulence regulation with persistence and population dynamics (18).
Particular attention has focused on the type III secretion system (T3SS), which injects effectors directly into host cells. The canonical effectors ExoS, ExoT, ExoU and ExoY are not uniformly distributed across P. aeruginosa lineages and encode distinct pathogenic strategies (16, 19–21). ExoS has ADP-ribosyltransferase and GTPase-activating activities that disrupt cytoskeletal and signaling pathways, whereas ExoU is a potent phospholipase associated with rapid cytotoxicity in experimental and human clinical settings (16, 21). ExoT is widely conserved and interferes with cytoskeletal dynamics and phagocytosis, while ExoY is a host-activated nucleotidyl cyclase whose contribution depends on the wider effector context (16, 20). Although exoS and exoU are often mutually exclusive, genomic co-detection has occasionally been reported (7, 21, 22); however, assembly-level co-detection alone does not establish coding-sequence integrity, expression or functional co-expression.
Whole-genome sequencing has begun to clarify the population biology of canine otitis-associated P. aeruginosa. Recent European, Asian and national studies show that canine isolates are genetically diverse, span multiple phylogenetic backgrounds and sequence types, and generally do not form a host-restricted lineage (4–8, 22, 23). A multinational analysis found no canine-specific virulence profile and showed that virulence-gene complement did not define a single otitis-associated cluster, despite frequent strong biofilm formation (7). Comparable studies in other animal-associated bacterial populations have likewise shown that virulence-marker distributions can vary substantially among isolates and should therefore be interpreted within their host, epidemiological and genomic context rather than as uniform species-level signatures (24). A later Hungarian cohort collected in 2024 similarly displayed a broad conserved virulence background but heterogeneous T3SS effector content, including exoU in 15 of 70 isolates (22). These findings support an opportunistic model in which widely distributed environmental lineages exploit the inflamed ear rather than a model based on a unique canine-adapted pathotype.
Historical collections remain valuable because they provide a baseline against which contemporary populations can be interpreted. However, gene absence in draft genomes and database-derived virulomes—the predicted virulence-associated gene repertoire—is particularly vulnerable to assembly quality, allele divergence and threshold selection. Absence-sensitive analyses therefore require stringent genome-quality filtering, explicit reporting of identity and coverage thresholds and sensitivity analyses at alternative thresholds (25–34). The present study examined an independent historical collection of canine otitis-associated isolates obtained in Hungary in 2010 and 2017. This historical collection is distinct from the later Hungarian cohort sampled in 2024 and characterized in complementary virulence- and resistance-focused studies (22, 23). Our objectives were to define the conserved and accessory virulence architecture, resolve T3SS effector virulotypes, assess whether virulome composition differed between the two collection years, and quantify the sensitivity of selected findings to genome-quality and VFDB threshold choices.
2. Materials and methods
2.1. Study design and bacterial isolates
This retrospective genomic study used an archival strain collection maintained at the Department of Pharmacology and Toxicology, University of Veterinary Medicine Budapest. The nominal collection comprised isolate identifiers 70–139, corresponding to 70 bacterial entries obtained from canine otitis externa cases in Hungary during 2010 and 2017. Isolates had been collected during routine diagnostic investigations and cryopreserved before the present study was initiated. Only one clinical isolate per dog was included in the analytical collection, and no dog contributed more than one isolate. Accordingly, the dataset contained no repeated within-dog observations from bilateral ear sampling, repeat visits or recurrent episodes of otitis. No prospective sampling, intervention or procedure involving live animals was performed. Sequencing was performed within a wider laboratory sequencing programme, but isolate assignment, quality control and all analyses reported here were handled as a separate historical cohort.
Virulence screening output was available for 60 assemblies within the nominal identifier range. For the remaining 10 nominal identifiers, no linked genome assembly and corresponding VFDB screening record were available in the archived analytical dataset. The historical records available for the present retrospective study did not permit the underlying reason for assembly unavailability to be reconstructed reliably; therefore, these entries were not included in genome-based analyses. Collection year was linked from the isolate register. Analyses were organized hierarchically to avoid treating low-quality assemblies as evidence of true gene absence. A genome-based species-confirmation screen was applied before genome-quality filtering, followed by a prespecified primary set used for prevalence and absence-sensitive analyses and a secondary QC-flagged set retained only for descriptive contextualization (Table 1; Figure 1).
Table 1.
Cohort definition and quality-control structure.
| Analytical stage | n | Definition/disposition |
|---|---|---|
| Nominal identifier range | 70 | Isolate identifiers 70–139 from the historical 2010/2017 strain bank. |
| VFDB-linked assemblies | 60 | Assemblies with virulence-screening records. |
| Genome-confirmed P. aeruginosa set | 59 | Assemblies confirmed as P. aeruginosa by genome-wide ANI after exclusion of isolate 134; 52 proceeded to the primary set and seven to the QC-flagged descriptive set. |
| Primary set | 52 | CheckM completeness ≥95% and contamination ≤5%; used for prevalence and absence-sensitive analyses. |
| QC-flagged descriptive set | 7 | Failed one or both primary CheckM criteria; excluded from prevalence denominators and absence-sensitive analyses and retained only in the supplementary descriptive genome-topology visualization. |
| Primary set, 2010 | 29 | High-quality isolates linked to 2010. |
| Primary set, 2017 | 23 | High-quality isolates linked to 2017. |
Figure 1.

Cohort curation and quality-control flow for the historical canine otitis-associated Pseudomonas collection. The nominal identifier range contained 70 entries; 60 had linked VFDB-screened assemblies. Isolate 134 was excluded from P. aeruginosa-specific analyses after genome-based taxonomic validation showed that it did not meet the species-level ANI criterion. Primary absence-sensitive analyses used 52 high-quality genomes; seven QC-flagged genome-confirmed P. aeruginosa assemblies were excluded from prevalence denominators and retained only in the supplementary descriptive genome-topology visualization.
Isolates originated from diagnostic ear-swab submissions from dogs diagnosed with otitis externa in Hungarian small-animal practices in 2010 or 2017. The archived isolates were provided through the veterinary diagnostic laboratory collection used for this retrospective study. Clinic-level identifiers and sufficiently detailed geographical metadata were not retained in the historical archive and were therefore unavailable for stratified analysis. Both year groups originated from the same general context of routine diagnostic submissions rather than from a prospectively standardized sampling programme. Consequently, although the overall sampling context was comparable, equivalence of the underlying clinic and source populations between 2010 and 2017 cannot be demonstrated retrospectively. Primary isolation was performed on cetrimide medium (Biolab Zrt., Budapest, Hungary) using colony morphology and characteristic pigment production. Archived isolates were revived and re-identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) using a Microflex LT instrument and the MALDI Biotyper system (Bruker Daltonics, Bremen, Germany) equipped with MBT Compass software v4.1 before genomic analysis using the 2026 reference library. Only isolates identified as P. aeruginosa with a MALDI Biotyper log(score) ≥ 2.0 were accepted as species-level identifications and included in the archived P. aeruginosa collection.
2.2. DNA extraction, long-read sequencing and assembly
Genomic DNA was extracted from pure bacterial cultures using the Quick-DNA Fungal/Bacterial Miniprep Kit (Zymo Research, Irvine, CA, United States) according to the manufacturer’s instructions. Native barcoded libraries were prepared using the Oxford Nanopore Technologies Native Barcoding Kit 24 V14 (SQK-NBD114.24) and sequenced on R10.4.1 MinION flow cells with a MinION Mk1B device. Base calling was performed with Dorado v7.6.8 through MinKNOW v24.11.10 using the super-accuracy model. Adapter and lambda-control sequences were removed with NanoLyse v1.2.1; NanoFilt v2.8.0 was used to trim 50 nucleotides from each read end and remove reads with mean quality below 8 or length below 500 bp. Read-quality summaries were generated with NanoPlot v1.43.0, as implemented in NanoPack (28).
De novo assemblies were generated with Flye v2.9.5-b1801 (29). Long reads were aligned back to the assemblies with minimap2 v2.28 (30), corrected with Racon v1.5.0 (31), and subsequently polished with Medaka v2.0.1 using the r1041_e82_400bps_sup_v4.2.0 model. Assembly statistics were evaluated using QUAST v5.0.2 (32). Per-isolate assembly length, contig count, assembly N50, CheckM completeness and contamination, and BUSCO completeness metrics are reported in Supplementary Table S1. Although NanoPlot was used for read-level quality assessment during the original sequencing workflow, the corresponding per-isolate summary outputs were not retained with the historical analytical dataset; consequently, read N50 and read-depth estimates could not be reported retrospectively without reprocessing the original reads. No assembly was classified as a formally closed chromosome because circularization and chromosome closure were not independently validated.
2.3. Genome quality and cohort definition
Assembly completeness and contamination were assessed using BUSCO v5.8.2 in auto-lineage mode (33) and CheckM v1.2.4 (34). Assemblies were considered high quality for the primary absence-sensitive analysis when CheckM completeness was at least 95% and contamination did not exceed 5%. Seven genome-confirmed P. aeruginosa assemblies failed one or both CheckM criteria and were therefore excluded from prevalence denominators and all absence-sensitive analyses. These QC-flagged genomes were retained only for descriptive placement in the supplementary core-genome visualization (Supplementary Figure S4); their positive VFDB calls were not used as a formal sensitivity analysis and no biological conclusion was tested on the basis of this secondary set.
Because isolate 134 showed marked genomic discordance with the remainder of the cohort, formal genome-based taxonomic validation was performed before final cohort definition. Average nucleotide identity was calculated using FastANI against the canonical Pseudomonas aeruginosa reference genomes PAO1 (GCF_000006765.1), PA14 (GCF_000014625.1) and LESB58 (GCF_000026645.1). The resulting ANI estimates were 80.24, 80.34 and 81.09%, respectively, all far below the conventional 95% species boundary for P. aeruginosa. The corresponding FastANI alignment fractions were 820/2000 fragments (41.0%) for PAO1, 828/2000 (41.4%) for PA14 and 862/2000 (43.1%) for LESB58. Because these ANI estimates lie near the lower operating range of the fragment-mapping approach, they were interpreted conservatively as evidence of marked genomic divergence from canonical P. aeruginosa references rather than as precise estimates of interspecies relatedness. Because the purpose of these comparisons was solely to determine whether isolate 134 could be retained within the P. aeruginosa analytical cohort, and because the low-identity, partial-fragment matches were not considered sufficient for a robust alternative species assignment, no alternative taxonomic identity was inferred. To place genome inclusion and exclusion on the same taxonomic footing, the FastANI analysis was subsequently extended to all 59 retained assemblies using PAO1 (GCF_000006765.1) as the reference genome. All 59 retained assemblies exceeded the conventional 95% ANI species boundary for P. aeruginosa, providing genome-based confirmation of their classification as P. aeruginosa. Isolate 134 was therefore treated as taxonomically discordant and excluded from the analytical cohort and from all P. aeruginosa-specific analyses.
2.4. Virulence-factor detection and functional organization
Genome assemblies were screened using ABRicate v1.4.0 against the Virulence Factor Database (VFDB; database accessed 2 April 2026) (25–27). The primary call set required at least 80% nucleotide identity and at least 80% reference-sequence coverage. Multiple hits to the same gene within an isolate were collapsed to a single presence call, retaining the highest-identity/highest-coverage match for descriptive summaries. A stricter joint threshold of 90% nucleotide identity and 90% reference-sequence coverage was used as a sensitivity analysis for selected genes. Because identity and coverage were increased simultaneously, this analysis was designed to assess sensitivity to overall call-stringency rather than to distinguish the independent effects of nucleotide identity and reference coverage. Because VFDB is reference dependent, missing calls were interpreted as failure to meet the stated homology criteria rather than definitive biological deletion, particularly for allele-diverse loci.
VFDB factor labels were mapped into 12 biologically interpretable modules: alginate and biofilm matrix; type IV pili and adhesion; flagellar motility; lipopolysaccharide; iron acquisition; phenazine and pyocyanin; quorum sensing and rhamnolipid; type II secretion; type III secretion apparatus; type III secretion effectors; type VI secretion; and secreted toxins and enzymes. Module completeness for each isolate was calculated as the proportion of the cohort-defined union of genes in that module detected in the isolate. Isolate-level module-completeness patterns were visualized as a heatmap (Supplementary Figure S3). Virulence genes were categorized as core-like (present in at least 95% of primary genomes), soft core (90 to <95%), shell (15 to <90%) or cloud (<15%). These categories describe prevalence within this cohort and are not intended as species-wide pangenome definitions.
2.5. Type III secretion effector virulotypes and supplementary core-genome visualization
T3SS effector profiles were defined from exoS, exoU, exoT and exoY calls. For the principal comparison, isolates were classified as exoS+/exoU−, exoU+/exoS−, exoS+/exoU+ or exoS−/ exoU−. Full four-effector profiles for all 52 high-quality genomes were retained in Supplementary Table S6. The isolate showing simultaneous exoS and exoU calls was subjected to additional sequence-level validation against the canonical PAO1 exoS (PA3841) and PA14 exoU (PA14_51530) loci. Reference coverage, nucleotide identity, contig localization and coding-sequence integrity were examined directly in the assembled genome. No independent read-level, PCR or Sanger confirmation of single-nucleotide sequence variation at the exoU-homologous locus was available. Accordingly, any apparent single-base indel observed in the long-read-only assembly was treated as unverified and potentially attributable to residual sequencing or assembly error. Effector calls were therefore interpreted strictly as genomic homology evidence and not as confirmation of intact coding sequence or functional protein production.
Genome assemblies were annotated using Prokka v1.14.6, and the resulting GFF3 files were used as input to Panaroo v1.8.0 (35). Maximum-likelihood inference was performed in IQ-TREE v3.0.1 (36) using the fast tree-search option and automatic model selection (−fast -m MFP); ModelFinder (37) selected GTR + F + I + R5 according to the Bayesian information criterion. The original phylogenetic analysis contained 61 assemblies. For visualization of the historical study cohort, isolate 134 and the non-cohort isolate 146 were pruned from the resulting topology, leaving 59 historical assemblies. No bootstrap or SH-aLRT resampling was performed. The resulting topology was visualized and annotated in the Interactive Tree of Life (iTOL) v6 (38) with collection year, genome-quality status, T3SS genomic profile and selected virulence-gene calls. Because the topology lacked branch-support resampling and external comparator genomes, it was retained only as a supplementary descriptive visualization of the historical cohort. It was not used for supported clade definition, lineage assignment, temporal population-structure inference, comparative cross-host phylogenomics, transmission inference, or any principal biological conclusion of the study.
2.6. Statistical analysis
Analyses were performed in Python 3.13 using NumPy and SciPy. Virulence-gene burden and module-level gene representation were summarized by medians and interquartile ranges. Differences between 2010 and 2017 were assessed using two-sided Mann–Whitney U tests for continuous or proportional module-level outcomes and Fisher exact tests for individual gene prevalence. Benjamini-Hochberg correction was applied separately to aggregate/module tests and gene-level tests; q < 0.05 was considered statistically significant. Effect direction and exact P and q values are reported rather than relying on significance labels alone.
Whole-virulome dissimilarity was calculated from the binary gene-presence matrix using Jaccard dissimilarity. To ensure consistency among ordination and inferential analyses and to address the non-Euclidean component of the untransformed Jaccard matrix, an element-wise square-root transformation was applied to the Jaccard dissimilarities. The same square-root-transformed Jaccard matrix was used for principal coordinates analysis (PCoA), PERMDISP and PERMANOVA. PCoA was performed by eigendecomposition of the double-centered squared-distance matrix, and the eigenvalue spectrum was inspected for negative eigenvalues. Homogeneity of multivariate dispersion between collection years was assessed using centroid-based PERMDISP with 9,999 permutations. The collection-year effect was tested using a one-way PERMANOVA with 9,999 unrestricted permutations of collection-year labels. A random seed of 20,260,711 was used for permutation analyses. Results are reported as F and permutation p values for PERMDISP and as pseudo-F, R2 and permutation p values for PERMANOVA.
3. Results
3.1. Cohort curation and genome quality
Of the 70 nominal isolate identifiers, 60 had linked genome assemblies and VFDB-screening records available for retrospective analysis; the remaining 10 identifiers lacked linked genomic data and were therefore not evaluable in the genome-based analyses. Genome-based taxonomic validation showed that isolate 134 was markedly inconsistent with Pseudomonas aeruginosa, with FastANI estimates of 80.24% against PAO1, 80.34% against PA14 and 81.09% against LESB58, all well below the conventional species-level boundary. The corresponding alignment fractions were 820/2,000 (41.0%), 828/2,000 (41.4%) and 862/2,000 (43.1%) fragments, respectively. Given the low ANI range, these values were interpreted as evidence of marked genomic divergence from the three canonical P. aeruginosa references rather than as precise measures of relatedness to an alternative species. No alternative species assignment was inferred. Isolate 134 was therefore excluded before P. aeruginosa-specific analysis, leaving 59 historical genomes in the analytical genome-confirmed P. aeruginosa set. Genome-based species confirmation was additionally extended to all 59 retained assemblies using PAO1 as the FastANI reference; every retained assembly exceeded the conventional 95% ANI species boundary for P. aeruginosa. Detailed per-isolate assembly, genome-quality and PAO1 ANI metrics, including assembly length, contig count, assembly N50, CheckM completeness and contamination, and BUSCO results, are provided in Supplementary Table S1. None of the assemblies was designated as a formally closed chromosome.
3.2. The historical cohort carried a dense, predominantly core-like virulence repertoire
The 52 high-quality genomes contained 242 distinct VFDB-associated genes at the primary threshold (Supplementary Table S2). The median isolate carried 230.5 genes (interquartile range 226.75–232.0; range 218–240). Of the cohort-wide repertoire, 217 genes were core-like, one was soft core, 22 were shell and two were cloud genes (Supplementary Figure S1). Thus, 90.1% of all detected genes occurred in at least 90% of high-quality genomes, defining a highly conserved virulence backbone despite isolate-level variation (Figure 2).
Figure 2.

Prevalence of selected virulence-associated genes among the 52 high-quality Pseudomonas aeruginosa genomes. Bars show the percentage of primary genomes with a VFDB call meeting at least 80% nucleotide identity and 80% reference coverage. Numbers at bar ends indicate positive genomes/52. The dashed line marks the 95% core-like threshold.
The core-like component included complete or near-complete alginate biosynthesis and regulation, type II and type III secretion apparatuses, HSI-I/HSI-1 type VI secretion components, phenazine and pyocyanin pathways, rhamnolipid biosynthesis, major extracellular proteases and most pyochelin-associated genes. The cohort-level density of these calls indicates that genetic determinants associated with attachment, matrix production, nutrient acquisition, secreted enzymes and interbacterial competition were broadly represented across the collection. Functional activity of these systems was not assessed in the present study.
3.3. Biofilm, adhesion, motility and iron-acquisition systems
Canonical alginate-associated genes, including algD, alg8 and alg44, were detected in all 52 high-quality genomes. The type IV pilus assembly and retraction backbone was likewise strongly conserved: pilB, pilT and fimV occurred in every primary genome. In contrast, the reference pilA call was detected in only 2/52 isolates, whereas most other pilus genes remained common. This pattern is more consistent with allelic divergence of the major pilin reference sequence than with wholesale loss of type IV pili, particularly because the broader pilus-associated gene repertoire was retained and the stricter threshold further reduced rather than rescued the pilA call. The flagellar regulator fleQ was universal, while the reference fliC allele was detected in 24/52 genomes (46.2%), again indicating locus-level sequence diversity within an otherwise conserved motility system (Figure 3).
Figure 3.

Selected virulence-gene presence/absence matrix for the 52 high-quality genomes. Isolates were ordered by average-linkage hierarchical clustering of whole-virulome Jaccard distances; genes were arranged by functional category. Dark blue denotes genomic detection at ≥80% nucleotide identity and ≥80% reference coverage, whereas pale blue denotes no call meeting both thresholds. The upper strip indicates collection year (light blue, 2010; dark blue, 2017). Apparent absence in allele-diverse loci should be interpreted as reference-threshold non-detection rather than confirmed functional deletion.
Iron-acquisition capacity was similarly distributed across conserved and variable components. pvdS and pvdA were detected in all primary genomes, and pchF was universal; pchE occurred in 51/52. By contrast, the specific VFDB reference calls for pvdD, pvdE and fpvA were each detected in 16/52 genomes. The shared prevalence pattern of these pyoverdine-associated loci and their preservation under the stricter threshold for the positive subset suggest lineage-associated allele configurations rather than random assembly loss. Because siderophore loci are sequence-diverse, these prevalence values should be interpreted as reference-homology groups, not as direct measures of functional siderophore deficiency.
3.4. Quorum sensing, phenazines and secreted tissue-damaging factors were widely conserved
The quorum-sensing synthase genes lasI and rhlI were detected in 50/52 (96.2%) and 51/52 (98.1%) genomes, respectively, while rhlA, rhlB, phzM and phzS occurred in all isolates. The available VFDB output did not support a reliable absence analysis for every regulatory receptor and pathway component; accordingly, absence of uncalled regulators was not inferred. The observed pattern indicates widespread genomic representation of loci associated with acyl-homoserine-lactone, rhamnolipid and phenazine/pyocyanin biosynthesis.
Secreted toxins and enzymes were also nearly ubiquitous. lasA, lasB and aprA were present in 52/52 genomes, whereas toxA and plcH were present in 51/52. The complete xcp type II secretion backbone, represented by universal xcpQ and associated components, provides the secretion machinery required for multiple extracellular products. These results indicate that differences among historical strains were not driven by broad loss of the major proteolytic and cytotoxic repertoire.
3.5. T3SS apparatus conservation contrasted with effector heterogeneity
Genes encoding the T3SS apparatus, including pscC and pscN, were detected in all primary genomes. Effector prevalence was less uniform: exoT was present in 52/52 (100%), exoY in 50/52 (96.2%), exoS in 49/52 (94.2%) and exoU in 4/52 (7.7%) (Table 2; Figure 3). Forty-eight isolates were exoS+/exoU−, three were exoU+/exoS−, and one 2010 isolate (isolate 89) showed assembly-level co-detection of exoS and exoU homologues (Figure 4; Table 3; Supplementary Table S6). Assembly-level inspection of isolate 89 showed full-length alignment of both loci. The exoS sequence showed 100% reference coverage and 99.49% nucleotide identity to PAO1 exoS. The exoU-homologous sequence covered 100% of the PA14 exoU reference, while the assembled sequence contained an apparent single-nucleotide insertion relative to the reference. In the assembly, this difference would alter the predicted reading frame; however, because no independent read-level or Sanger confirmation was available, the apparent insertion and resulting frameshift remain unverified and may represent residual long-read sequencing or assembly error. The exoU call was therefore interpreted only as evidence of an exoU-homologous genomic sequence and not as evidence either for or against production of an intact functional ExoU effector. The two homologous loci occurred on separate assembly contigs.
Table 2.
Prevalence of selected virulence-associated genes in the 52 high-quality genomes.
| Functional group | Gene | Present | Prevalence (%) | Median identity (%) |
|---|---|---|---|---|
| Biofilm/matrix | algD | 52/52 | 100.0 | 100.0 |
| Biofilm/matrix | alg44 | 52/52 | 100.0 | 99.7 |
| Adhesion/motility | pilB | 52/52 | 100.0 | 88.5 |
| Adhesion/motility | pilT | 52/52 | 100.0 | 99.7 |
| Adhesion/motility | fimV | 52/52 | 100.0 | 99.3 |
| Adhesion/motility | fliC | 24/52 | 46.2 | 99.9 |
| Iron acquisition | pvdS | 52/52 | 100.0 | 99.5 |
| Iron acquisition | pvdA | 52/52 | 100.0 | 99.0 |
| Iron acquisition | fpvA | 16/52 | 30.8 | 99.8 |
| Iron acquisition | pchE | 51/52 | 98.1 | 99.5 |
| Quorum sensing/exoproducts | lasI | 50/52 | 96.2 | 100.0 |
| Quorum sensing/exoproducts | rhlI | 51/52 | 98.1 | 98.5 |
| Quorum sensing/exoproducts | rhlA | 52/52 | 100.0 | 99.5 |
| Quorum sensing/exoproducts | phzM | 52/52 | 100.0 | 99.7 |
| Secreted toxins/enzymes | toxA | 51/52 | 98.1 | 99.3 |
| Secreted toxins/enzymes | lasA | 52/52 | 100.0 | 99.3 |
| Secreted toxins/enzymes | lasB | 52/52 | 100.0 | 99.7 |
| Secreted toxins/enzymes | aprA | 52/52 | 100.0 | 99.6 |
| Secreted toxins/enzymes | plcH | 51/52 | 98.1 | 99.7 |
| T3SS effectors | exoT | 52/52 | 100.0 | 99.1 |
| T3SS effectors | exoY | 50/52 | 96.2 | 99.6 |
| T3SS effectors | exoS | 49/52 | 94.2 | 99.6 |
| T3SS effectors | exoU | 4/52 | 7.7 | 99.9 |
| Secretion systems | pscC | 52/52 | 100.0 | 99.7 |
| Secretion systems | xcpQ | 52/52 | 100.0 | 99.6 |
| Secretion systems | hcp1 | 52/52 | 100.0 | 100.0 |
| Secretion systems | icmF1/tssM1 | 52/52 | 100.0 | 99.5 |
Identity values summarize the highest-scoring call per gene per isolate among positive genomes. Complete gene-level prevalence, median identity and median coverage data are provided in Supplementary Table S2.
Figure 4.

Distribution of principal type III secretion effector genomic profiles by collection year. Profiles were defined from VFDB-based genomic detection of exoS and exoU in the 52 high-quality genomes; exoT was detected in all isolates and exoY in all but two. One 2010 isolate showed assembly-level genomic co-detection of exoS and an exoU-homologous sequence. Assembly-level sequence inspection supported two distinct homologous loci, but no independent read-level, PCR or Sanger confirmation was available; therefore, coding-sequence integrity and functional co-expression of the corresponding effector proteins are not inferred.
Table 3.
Principal T3SS effector virulotypes by collection year.
| Virulotype | 2010, n (%) | 2017, n (%) | Total, n (%) |
|---|---|---|---|
| exoS+/exoU− | 28 (96.6) | 20 (87.0) | 48 (92.3) |
| exoU+/exoS− | 0 (0.0) | 3 (13.0) | 3 (5.8) |
| exoS+/exoU+ | 1 (3.4) | 0 (0.0) | 1 (1.9) |
| exoS-/exoU− | 0 (0.0) | 0 (0.0) | 0 (0.0) |
The exoS+/exoU+ category denotes threshold-based genomic co-detection. In isolate 89, assembly-level sequence inspection identified both homologues. The assembled exoU-homologous sequence contained an apparent single-nucleotide insertion that would alter the predicted reading frame; however, this indel was not independently confirmed and may represent residual long-read sequencing or assembly error. Neither intact exoU coding sequence nor functional ExoU production is therefore inferred.
The distribution differed descriptively between years: all 29 isolates from 2010 carried exoS, whereas 20/23 isolates from 2017 were exoS-positive; the three exoS-negative 2017 isolates carried exoU. However, the year association for exoS did not remain significant after correction across the full gene set (unadjusted p = 0.080; q = 1.000), and the difference in exoU prevalence was also non-significant (p = 0.310; q = 1.000).
3.6. Supplementary core-genome visualization
For completeness, the previously generated core-genome topology of the historical cohort is provided as Supplementary Figure S4. No bootstrap or SH-aLRT resampling was performed in the original analysis. Because branch support was therefore unavailable, the topology was not used to infer supported relationships among isolates. It was retained only as a supplementary descriptive visualization of the historical cohort and was not used for clade definition, lineage assignment, temporal population-structure inference, comparative cross-host phylogenomics, transmission inference, or any principal biological conclusion of the study.
3.7. No detectable whole-virulome shift between 2010 and 2017
Total virulence-gene burden and module-completeness measures likewise showed no statistically significant collection-year differences after Benjamini-Hochberg correction (all q ≥ 0.724; Table 4). PCoA based on square-root-transformed Jaccard dissimilarities showed substantial intermingling of the 2010 and 2017 profiles, with the first two axes explaining 39.9 and 24.5% of the positive-eigenvalue variation, respectively (Figure 5). Multiple isolates shared identical or highly similar binary virulome profiles and consequently occupied identical or closely overlapping positions in the two-dimensional ordination. The untransformed Jaccard matrix generated 12 negative eigenvalues (most negative eigenvalue, −0.00641; summed absolute negative eigenvalues equivalent to 25.8% of the summed positive eigenvalues), whereas no negative eigenvalues remained after square-root transformation. PERMDISP did not reach statistical significance (F = 4.051, p = 0.0902). PERMANOVA using the same square-root-transformed Jaccard matrix showed that collection year explained only 1.34% of whole-virulome variation (pseudo-F = 0.678, R2 = 0.0134, p = 0.6083). No individual gene was associated with year after correction (minimum q = 1.000; Supplementary Table S4).
Table 4.
Collection-year comparisons of total virulence-gene burden and module completeness.
| Feature | 2010 median (IQR) | 2017 median (IQR) | P | q |
|---|---|---|---|---|
| Total virulence-gene count | 228 (227.0–232.0) | 232 (226.0–233.0) | 0.595 | 0.968 |
| Alginate and biofilm matrix | 1 (1.000–1.000) | 1 (1.000–1.000) | 1.000 | 1.000 |
| Type IV pili and adhesion | 0.97 (0.939–0.970) | 0.939 (0.939–0.970) | 0.257 | 0.724 |
| Flagellar motility | 0.87 (0.870–1.000) | 0.87 (0.870–1.000) | 0.751 | 0.976 |
| Lipopolysaccharide | 0.714 (0.714–0.714) | 0.714 (0.714–1.000) | 0.073 | 0.724 |
| Iron acquisition | 0.848 (0.848–0.970) | 0.848 (0.848–1.000) | 0.471 | 0.968 |
| Phenazine and pyocyanin | 1 (1.000–1.000) | 1 (1.000–1.000) | 0.278 | 0.724 |
| Quorum sensing and rhamnolipid | 1 (1.000–1.000) | 1 (1.000–1.000) | 0.715 | 0.976 |
| Type II secretion | 1 (1.000–1.000) | 1 (1.000–1.000) | 1.000 | 1.000 |
| Type III secretion apparatus | 1 (1.000–1.000) | 1 (1.000–1.000) | 1.000 | 1.000 |
| Type III secretion effectors | 0.75 (0.750–0.750) | 0.75 (0.750–0.750) | 0.538 | 0.968 |
| Type VI secretion | 1 (1.000–1.000) | 1 (1.000–1.000) | 0.278 | 0.724 |
| Secreted toxins and enzymes | 1 (1.000–1.000) | 1 (1.000–1.000) | 0.115 | 0.724 |
Module completeness is the proportion of the cohort-defined union of genes in each functional module detected in an isolate. p-values are from two-sided Mann–Whitney U tests; q-values are Benjamini-Hochberg adjusted across the 13 aggregate comparisons.
Figure 5.

Principal coordinates analysis of square-root-transformed whole-virulome Jaccard dissimilarities among the 52 high-quality genomes. All 52 genomes are represented. Symbols indicate collection year. At coordinates representing multiple genomes, numeric labels adjacent to each symbol indicate the number of genomes from the corresponding collection year represented at that coordinate; a value of 1 is shown when a single genome from 1 year coincides with genomes from the other year. Unlabelled symbols represent single genomes at non-coincident coordinates. Point positions correspond to the original PCoA coordinates and were not jittered. The first two axes explain 39.9 and 24.5% of the positive-eigenvalue variation, respectively. No negative eigenvalues remained after square-root transformation. The same distance matrix was used for PERMDISP and PERMANOVA; PERMDISP did not reach statistical significance (F = 4.051, p = 0.0902), and the collection-year effect was not significant (PERMANOVA: Pseudo-F = 0.678, R2 = 0.0134, p = 0.6083; 9,999 permutations).
3.8. Joint identity/coverage stringency affected selected gene calls
Most key findings were stable when the joint VFDB criterion was increased from 80% nucleotide identity and 80% reference coverage to 90% identity and 90% coverage. Universal or near-universal calls for algD, alg8, alg44, pilT, fimV, pvdS, pchE, rhlA, rhlB, phzM, phzS, toxA, lasA, lasB, aprA, plcH, exoT, exoY, exoS, exoU, pscC, pscN, xcpQ, hcp1 and icmF1/tssM1 were unchanged or changed minimally (Supplementary Figure S2; Supplementary Table S5). In contrast, pilB decreased from 52/52 to 13/52 and pvdA from 52/52 to 30/52 under the joint 90/90 criterion. The primary-threshold median identity was 88.5% for pilB but approximately 99.0% for pvdA (Table 2), suggesting that nucleotide identity plausibly contributed substantially to the reduction in pilB calls, whereas reference coverage may have contributed more strongly to the reduction in pvdA calls. Because identity and coverage were changed simultaneously, however, their individual contributions cannot be quantified from this sensitivity analysis. The results therefore demonstrate sensitivity of selected VFDB calls to overall homology-stringency rather than specifically to nucleotide-identity thresholds.
4. Discussion
This study defines the virulence-associated genomic architecture of an independent historical Hungarian collection of canine otitis-associated P. aeruginosa. The 52 high-quality genomes carried a dense, predominantly conserved virulence repertoire, whereas heterogeneity was concentrated in T3SS effectors and allele-diverse surface-structure and pyoverdine-associated loci. Neither total virulence-gene burden nor multivariate virulome composition differed detectably between 2010 and 2017. The conclusions regarding virulence-gene conservation, heterogeneity and collection-year comparisons are based on genomic prevalence and multivariate analyses. The previously generated core-genome topology is provided only as supplementary descriptive material and is not used as inferential evidence.
The external ear in chronic otitis is a selective environment characterized by epithelial disruption, altered lipid and moisture conditions, inflammatory exudate, repeated cleaning and frequent antimicrobial exposure. Persistence in this niche requires more than a single toxin. Conserved flagellar and type IV pilus systems support motility and initial attachment; alginate and other exopolysaccharide pathways support matrix production and spatial organization; siderophores secure iron under host limitation; quorum sensing coordinates density-dependent exoproducts; and secreted proteases, phospholipases and exotoxin A can damage tissue or modulate local defenses (9–15). The near-universal presence of these systems is therefore consistent with the broad ecological versatility of P. aeruginosa and with canine studies showing frequent strong biofilm formation (2, 7, 14, 15, 39).
The data should not be interpreted as proof that every gene was expressed in the diseased ear. VFDB screening identifies genomic homologues, not transcription, secretion, enzymatic activity or clinical severity. Biofilm formation, for example, depends on regulation, environmental conditions and lineage-specific matrix use; some strains rely more heavily on Pel than Psl, and gene presence alone does not predict the magnitude of a biofilm phenotype (14, 15). Nevertheless, conservation of the underlying machinery provides a credible genomic substrate for persistence. This distinction is clinically relevant: antimicrobial susceptibility testing addresses planktonic growth inhibition, whereas virulome content and biofilm physiology address different dimensions of pathogenesis and treatment failure (2, 40). Local control measures may therefore complement antimicrobial treatment. Stabilized hypochlorous acid has documented activity against P. aeruginosa and has been proposed for veterinary hygiene applications, although formulation-specific efficacy, biofilm activity, otic tolerability and clinical performance require direct validation (41). Antimicrobial peptides represent another potential non-conventional approach because of their membrane-targeting, immunomodulatory and anti-biofilm properties, but stability, delivery, toxicity and in vivo efficacy remain important translational limitations (42).
The T3SS apparatus was universal, but its effector repertoire was not. The dominant historical profile was exoS+/exoU−, consistent with the widespread distribution of exoS-positive lineages and with several canine datasets (7, 39). In the multinational study of 35 sequenced canine otitis isolates, exoS occurred in 24/35 and exoU in 5/35; one isolate carried both and five carried neither (7). Hattab et al. (39) detected exoS in 21/24 canine clinical isolates. Our cohort contained exoS calls in 49/52 and exoU calls in 4/52 genomes. One isolate showed assembly-level co-detection of both homologues. The assembled exoU-homologous sequence contained an apparent single-nucleotide insertion that would alter the predicted reading frame. However, because this observation derives from a long-read-only assembly and was not independently confirmed at read level or by Sanger sequencing, the apparent indel and associated frameshift cannot be distinguished confidently from residual sequencing or assembly error. This isolate should therefore be regarded as carrying genomic homologues of both exoS and exoU, without inference regarding the intactness or functional expression of the ExoU effector.
Comparison with the independent 2024 Hungarian cohort is informative but must remain descriptive because sampling, selection and quality-control structures differ. In the later collection, exoS was detected in 50/70 isolates and exoU in 15/70, compared with 49/52 and 4/52, respectively, in the present primary historical set (22). The proportion of exoU-positive isolates was descriptively higher in the 2024 cohort than in the historical cohort. However, because the cohorts differed in sampling, isolate selection and quality-control structure, this observation should not be interpreted as evidence of a temporal increase. The 2024 genomes were selected from a different clinical collection and no joint population model or harmonized sampling frame was available. A future analysis using all genomes under a single assembly, species-confirmation and variant-calling pipeline would be required to test temporal replacement formally.
The single genome showing exoS/exoU co-detection deserves cautious attention because these genes are commonly, but not absolutely, mutually exclusive (7, 21). Both homologues independently met the predefined VFDB calling criteria in a high-quality assembly and were therefore retained as a genomic observation. Targeted assembly-level inspection supported the presence of both homologous loci on separate contigs. However, no independent read-level, PCR or Sanger confirmation was available. In particular, the apparent single-base indel observed in the assembled exoU-homologous sequence remains unverified and may represent residual error in the long-read-only assembly. We therefore describe the finding strictly as genomic co-detection and make no inference regarding intact exoU coding sequence, functional co-expression or secretion competency (16, 21). The observation should therefore be regarded as an uncommon genomic configuration that warrants targeted validation in future studies.
Universal type II secretion components and near-universal extracellular-enzyme homologues indicate that genes associated with extracellular-protein secretion were broadly conserved across the collection. LasA, LasB, AprA, PlcH and exotoxin A act through distinct mechanisms, including proteolysis of host substrates, membrane damage and inhibition of protein synthesis (10–13). Their conservation may help explain why chronic pseudomonal otitis can remain destructive even when no single unusual toxin profile is present.
The HSI-I/HSI-1 type VI secretion backbone was also strongly conserved. T6SSs contribute primarily to interbacterial competition, niche occupancy and delivery of toxic effectors, although context-dependent interactions with eukaryotic hosts are also described (17, 43). In a polymicrobial or dysbiotic ear canal, such machinery may influence competition with resident bacteria and thereby support persistence. However, our VFDB-based module analysis did not comprehensively resolve the highly variable orphan effector and immunity islands described in human clinical populations (17). The present result should therefore be interpreted as conservation of the secretion scaffold, not identity of the full T6SS effector repertoire.
Several low-prevalence calls occurred within systems whose wider machinery was nearly complete. The major pilin reference pilA was detected in only two genomes, while pilB, pilT, fimV and other pilus components were widespread. Similarly, the reference fliC allele occurred in fewer than half of genomes despite universal or near-universal flagellar structural and regulatory genes. Pyoverdine-associated pvdD, pvdE and fpvA calls co-occurred in a subset, while the general pyoverdine regulatory and biosynthetic backbone remained conserved. These patterns are characteristic of allelic and structural diversity in surface-exposed or siderophore-recognition loci, where reference-specific nucleotide thresholds can separate homologous families (7, 10, 44).
The joint 90/90 sensitivity analysis showed that most major virulome conclusions were robust to increased homology-stringency, whereas selected loci, particularly pilB and pvdA, were sensitive to the stricter combined criterion. Importantly, because nucleotide identity and reference coverage were increased simultaneously, the observed reductions cannot be attributed uniquely to either parameter. The relatively low median identity of pilB at the primary threshold is consistent with an identity-driven effect, whereas the approximately 99% median identity of pvdA indicates that incomplete reference coverage is a plausible contributor to its reduced detection under the 90/90 criterion. Accordingly, these results are interpreted as evidence of threshold sensitivity of database-based gene calls rather than as evidence of biological gene loss or specifically of nucleotide-sequence divergence (25, 26).
The absence of a detectable difference in virulome composition between the 2010 and 2017 collections should not be interpreted as evidence that the underlying population was static. The study sampled only two discrete years, the isolates represented an archival convenience collection, and highly conserved binary virulome matrices have limited power to distinguish population-level temporal change. The appropriate conclusion is therefore narrower: no broad temporal restructuring of virulence-gene content was detected with the present dataset, sampling density and analytical framework. Although PERMDISP was not statistically significant (p = 0.0902), the unequal group sizes (29 versus 23 isolates) warrant cautious interpretation because some contribution of dispersion differences to the PERMANOVA result cannot be excluded.
From a One Health perspective, the most directly relevant context is provided by genomic studies of Pseudomonas aeruginosa from companion animals and humans. Recent canine WGS studies have identified internationally recognized high-risk sequence types also encountered in human nosocomial populations and have shown substantial genomic diversity among canine isolates, without evidence for a single host-restricted population structure (4, 7, 8). Additional cross-host evidence comes from genomic investigations documenting closely related P. aeruginosa isolates in companion animals, humans and shared environments, as well as recent companion-animal surveillance identifying internationally distributed high-risk clones with links to human-associated lineages (45, 46). These findings support the importance of host-resolved comparative genomics when evaluating the One Health relevance of veterinary P. aeruginosa. More broadly, studies of antimicrobial resistance in wild birds, poultry and other farm animals illustrate how antimicrobial-resistance determinants and mobile genetic elements can occur across diverse animal reservoirs and reinforce the wider value of integrated One Health surveillance (47–49). Long-term antimicrobial-resistance trends in canine otitis pathogens further emphasize the clinical relevance of such surveillance in companion animals (50), while broader genomic frameworks provide a methodological basis for investigating antimicrobial resistance across One Health interfaces (51). The present study did not include human or environmental comparator genomes and therefore cannot establish cross-host transmission or zoonotic directionality. Its contribution is restricted to documenting virulence-associated genomic diversity within a veterinary clinical population; any assessment of cross-host risk should integrate comparative phylogenomics, sequence type, antimicrobial resistance, mobile genetic elements and epidemiological exposure data rather than virulence-gene presence alone.
The principal strengths are the use of an independent historical collection, long-read assemblies, explicit genome-quality filtering, a prespecified identity/coverage threshold, isolate-level source tables, false-discovery-rate control and sensitivity analysis at a stricter VFDB threshold. The distinction between a 52-genome primary set and seven QC-flagged genomes prevented incomplete assemblies from inflating absence estimates. Exclusion of a species-discordant assembly further protected the species-specific prevalence analysis from a major taxonomic outlier.
Several limitations remain. The collection was retrospective and not population based and therefore does not estimate national prevalence. Although only one isolate per dog was included, clinic-level identifiers and sufficiently detailed geographical metadata were unavailable, and the equivalence of the underlying source populations sampled in 2010 and 2017 cannot be demonstrated retrospectively. In addition, genomic data were unavailable for 10 of the 70 nominal isolate identifiers, and the historical records did not permit the reasons for this missingness to be reconstructed. Because the possibility of non-random assembly availability cannot be excluded, some selection bias in the genome-based analytical cohort is therefore possible. Consequently, collection-year comparisons may be influenced by unmeasured differences in the populations submitting diagnostic samples and should not be interpreted as population-level temporal surveillance. Clinical metadata were also insufficient to associate virulome patterns with disease severity, chronicity, prior treatment, laterality, biofilm phenotype or outcome. Only two discrete sampling years were represented, limiting statistical power for temporal inference and precluding continuous trend modelling. Long-read-only assemblies may retain residual base errors after polishing, and no independent short-read confirmation or targeted PCR validation was available. Genome-based species confirmation was applied to all 59 retained assemblies, each of which exceeded the conventional 95% ANI boundary to PAO1. Isolate 134 was the sole taxonomically discordant assembly and was excluded before all P. aeruginosa-specific analyses. Its alternative species identity was not determined and is not inferred in the present study. VFDB calls are reference dependent and cannot distinguish pseudogenes, regulatory disruption, expression or secretion. Module completeness was defined against the cohort union rather than a curated essential-gene set. Because the core-genome tree was inferred without bootstrap or SH-aLRT resampling and was pruned from a wider analysis, it was restricted to descriptive visualization and was not used for formal clade, lineage, population-structure or transmission inference. Dedicated branch-supported phylogenomics based on a harmonized cohort would be required for such questions. Finally, the comparison with the 2024 Hungarian cohort was descriptive because the cohorts were not assembled through a unified sampling and analytical design.
5. Conclusion
Historical canine otitis-associated P. aeruginosa isolates from Hungary carried a dense and highly conserved virulence-associated genomic backbone encompassing loci associated with biofilm matrix formation, adhesion and motility, iron acquisition, quorum sensing, phenazine and rhamnolipid biosynthesis, extracellular enzymes, and type II, type III and type VI secretion systems. Strain-level heterogeneity was concentrated in T3SS effectors and allele-diverse surface or siderophore loci. The dominant profile was exoS+/exoU-, while exoU occurred in a small subset and one high-quality genome showed genomic co-detection of exoS and an exoU homologue. No statistically detectable difference in virulome composition was observed between the 2010 and 2017 collections. Overall, the data demonstrate a broadly conserved virulence-associated genomic repertoire accompanied by isolate-level heterogeneity in T3SS effector homologues and selected surface- and siderophore-associated loci. These genomic detections should not be interpreted as direct evidence of gene expression, protein production or functional pathogenicity. Functional studies integrating gene expression, secretion phenotypes, biofilm characteristics and clinical metadata will be required to determine how the identified genomic variation contributes to persistence and disease phenotype.
Acknowledgments
The authors thank Duo-Bakt Veterinary Microbiology Laboratory for providing the clinical isolates and the sequencing laboratory staff for technical support.
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This research was funded by Project no. RRF-2.3.1-21-2022-00001, implemented with the support provided by the Recovery and Resilience Facility (RRF), financed under the National Recovery Fund budget estimate, RRF-2.3.1–21 funding scheme.
Footnotes
Edited by: Nora Mestorino, National University of La Plata, Argentina
Reviewed by: Ayhan Filazi, Ankara University, Türkiye
Dawid Jańczak, Nicolaus Copernicus University in Toruń, Poland
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.
Ethics statement
The manuscript presents research on animals that do not require ethical approval for their study.
Author contributions
MV: Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing. BM: Project administration, Resources, Writing – review & editing. PM: Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – review & editing. EK: Formal analysis, Software, Validation, Writing – review & editing. EF: Resources, Software, Writing – review & editing. ÁJ: Conceptualization, Funding acquisition, Investigation, Validation, Writing – review & editing. ÁK: Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – review & editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2026.1951261/full#supplementary-material
References
- 1.O’Neill DG, Volk AV, Soares T, Church DB, Brodbelt DC, Pegram C. Frequency and predisposing factors for canine otitis externa in the UK-a primary veterinary care epidemiological view. Canine Med Genet. (2021) 8:7. doi: 10.1186/s40575-021-00106-1, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Secker B, Shaw S, Atterbury RJ. Pseudomonas spp. in canine otitis externa. Microorganisms. (2023) 11:2650. doi: 10.3390/microorganisms11112650, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rosales RS, Ramírez AS, Moya-Gil E, de la Fuente SN, Suárez-Pérez A, Poveda JB. Microbiological survey and evaluation of antimicrobial susceptibility patterns of microorganisms obtained from suspect cases of canine otitis externa in gran Canaria, Spain. Animals. (2024) 14:742. doi: 10.3390/ani14050742, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Elfadadny A, Uchiyama J, Goto K, Imanishi I, Ragab RF, Nageeb WM, et al. Antimicrobial resistance and genotyping of Pseudomonas aeruginosa isolated from the ear canals of dogs in Japan. Front Vet Sci. (2023) 10:1074127. doi: 10.3389/fvets.2023.1074127, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Płókarz D, Bierowiec K, Rypuła K. Screening for antimicrobial resistance and genes of exotoxins in Pseudomonas aeruginosa isolates from infected dogs and cats in Poland. Antibiotics. (2023) 12:1226. doi: 10.3390/antibiotics12071226, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jangsangthong A, Lugsomya K, Apiratwarrasakul S, Phumthanakorn N. Distribution of sequence types and antimicrobial resistance of clinical Pseudomonas aeruginosa isolates from dogs and cats visiting a veterinary teaching hospital in Thailand. BMC Vet Res. (2024) 20:234. doi: 10.1186/s12917-024-04098-5, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Secker B, Shaw S, Hobley L, Atterbury RJ. Genomic and phenotypic characterisation of Pseudomonas aeruginosa isolates from canine otitis externa reveals high-risk sequence types identical to those found in human nosocomial infections. Front Microbiol. (2025) 16:1526843. doi: 10.3389/fmicb.2025.1526843, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Newstead L, Smith-Zaitlik T, Kelly C, Roberts E, Street S, Paterson GK. Genomic characterization of Pseudomonas aeruginosa from canine otitis highlights the need for a one health approach to this opportunistic pathogen. Microb Genom. (2025) 11:001407. doi: 10.1099/mgen.0.001407, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Miranda SW, Asfahl KL, Dandekar AA, Greenberg EP. Pseudomonas aeruginosa Quorum Sensing. Adv Exp Med Biol. (2022) 1386:95–115. doi: 10.1007/978-3-031-08491-1_4, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Crone S, Vives-Flórez M, Kvich L, Saunders AM, Malone M, Nicolaisen MH, et al. The environmental occurrence of Pseudomonas aeruginosa. APMIS. (2020) 128:220–31. doi: 10.1111/apm.13010, [DOI] [PubMed] [Google Scholar]
- 11.Jurado-Martín I, Sainz-Mejías M, McClean S. Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci. (2021) 22:3128. doi: 10.3390/ijms22063128, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. (2022) 7:199. doi: 10.1038/s41392-022-01056-1, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhang X, Zhang D, Zhou D, Zheng S, Li S, Hou Q, et al. A comprehensive review of the pathogenic mechanisms of Pseudomonas aeruginosa: synergistic effects of virulence factors, quorum sensing, and biofilm formation. Front Microbiol. (2025) 16:1619626. doi: 10.3389/fmicb.2025.1619626, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Thi MTT, Wibowo D, Rehm BHA. Pseudomonas aeruginosa Biofilms. Int J Mol Sci. (2020) 21:8671. doi: 10.3390/ijms21228671, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thöming JG, Häussler S. Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey. Front Cell Infect Microbiol. (2022) 12:851784. doi: 10.3389/fcimb.2022.851784, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hardy KS, Tuckey AN, Housley NA, Andrews J, Patel M, Al-Mehdi A-B, et al. The Pseudomonas aeruginosa type III secretion system exoenzyme effector ExoU induces mitochondrial damage in a murine bone marrow-derived macrophage infection model. Infect Immun. (2022) 90:e0047021. doi: 10.1128/IAI.00470-21, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Robinson LA, Collins ACZ, Murphy RA, Davies JC, Allsopp LP. Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates. Front Microbiol. (2022) 13:1042505. doi: 10.3389/fmicb.2022.1042505, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kerek Á, Tornyos GÁ, Husz LH, Jerzsele Á. The role of quorum sensing in the population dynamics of antimicrobial resistance. Magy Allatorv Lapja. (2026) 148:415–26. doi: 10.56385/magyallorv.2026.7.415-426 [DOI] [Google Scholar]
- 19.Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. (2009) 7:654–65. doi: 10.1038/nrmicro2199, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Silistre H, Raoux-Barbot D, Mancinelli F, Sangouard F, Dupin A, Belyy A, et al. Prevalence of ExoY activity in Pseudomonas aeruginosa reference panel strains and impact on cytotoxicity in epithelial cells. Front Microbiol. (2021) 12:666097. doi: 10.3389/fmicb.2021.666097, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nolasco-Romero CG, Prado-Galbarro F-J, Jimenez-Juarez RN, Gomez-Ramirez U, Cancino-Díaz JC, López-Marceliano B, et al. The exoS, exoT, exoU and exoY Virulotypes of the type 3 secretion system in multidrug resistant Pseudomonas aeruginosa as a death risk factor in pediatric patients. Pathogens. (2024) 13:1030. doi: 10.3390/pathogens13121030, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Veres MA, Tóth ZA, Illés E, Mag P, Kaszab E, Fehér E, et al. Virulence-associated genomic architecture of canine otitis externa-derived Pseudomonas aeruginosa isolates from Hungary. Vet Sci. (2026) 13:664. doi: 10.3390/vetsci13070664, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Veres MA, Tóth ZA, Illés E, Mag P, Kaszab E, Fehér E, et al. Phenotypic antimicrobial susceptibility and genomic resistance determinants in canine otitis-associated Pseudomonas aeruginosa isolates. Front Vet Sci. (2026) 13:1902036. doi: 10.3389/fvets.2026.1902036, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.İnce SS, Akan M. Distribution of antimicrobial resistance and virulence markers in chicken originated Proteus mirabilis isolates. Acta Vet Hung. (2024) 72:11–20. doi: 10.1556/004.2023.00990, [DOI] [PubMed] [Google Scholar]
- 25.Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res. (2022) 50:D912–7. doi: 10.1093/nar/gkab1107, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liu B, Zheng D, Jin Q, Chen L, Yang J. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. (2019) 47:D687–92. doi: 10.1093/nar/gky1080, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Seemann T. Tseemann/Abricate (2025) Available online at: https://github.com/tseemann/abricate (Accessed December 29, 2025)
- 28.De Coster W, D’Hert S, Schultz DT, Cruts M, Van Broeckhoven C. NanoPack: visualizing and processing long-read sequencing data. Bioinformatics. (2018) 34:2666–9. doi: 10.1093/bioinformatics/bty149, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. (2019) 37:540–6. doi: 10.1038/s41587-019-0072-8, [DOI] [PubMed] [Google Scholar]
- 30.Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. (2018) 34:3094–100. doi: 10.1093/bioinformatics/bty191, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vaser R, Sović I, Nagarajan N, Šikić M. Fast and accurate de novo genome assembly from long uncorrected reads. Genome Res. (2017) 27:737–46. doi: 10.1101/gr.214270.116, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. (2013) 29:1072–5. doi: 10.1093/bioinformatics/btt086, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Manni M, Berkeley MR, Seppey M, Simão FA, Zdobnov EM. BUSCO update: novel and streamlined workflows along with broader and deeper phylogenetic coverage for scoring of eukaryotic, prokaryotic, and viral genomes. Mol Biol Evol. (2021) 38:4647–54. doi: 10.1093/molbev/msab199, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. (2015) 25:1043–55. doi: 10.1101/gr.186072.114, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tonkin-Hill G, MacAlasdair N, Ruis C, Weimann A, Horesh G, Lees JA, et al. Producing polished prokaryotic pangenomes with the Panaroo pipeline. Genome Biol. (2020) 21:180. doi: 10.1186/s13059-020-02090-4, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. (2020) 37:1530–4. doi: 10.1093/molbev/msaa015, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. (2017) 14:587–9. doi: 10.1038/nmeth.4285, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Letunic I, Bork P. Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. (2024) 52:W78–82. doi: 10.1093/nar/gkae268, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hattab J, Mosca F, Di Francesco CE, Aste G, Marruchella G, Guardiani P, et al. Occurrence, antimicrobial susceptibility, and pathogenic factors of Pseudomonas aeruginosa in canine clinical samples. Vet World. (2021) 14:978–85. doi: 10.14202/vetworld.2021.978-985, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res. (2002) 66:86–92. [PMC free article] [PubMed] [Google Scholar]
- 41.Jerzsele Á, Kerek Á, Kovács L, Könyves L, Sótonyi P. A classic disinfectant reimagined: the role of stabilized hypochlorous acid (HOCl) in modern hygiene. Magy Allatorv Lapja. (2025) 147:545–54. doi: 10.56385/magyallorv.2025.9.545-554 [DOI] [Google Scholar]
- 42.Sebők C, Márton RA, Mackei M, Neogrády Z, Mátis G. Antimicrobial peptides as new tools to combat infectious diseases. Magy Allatorv Lapja. (2024) 146:181–91. doi: 10.56385/magyallorv.2024.03.181-191 [DOI] [Google Scholar]
- 43.Hood RD, Singh P, Hsu F, Güvener T, Carl MA, Trinidad RRS, et al. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe. (2010) 7:25–37. doi: 10.1016/j.chom.2009.12.007, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tümmler B. Pseudomonas aeruginosa genomic structure and diversity. Front Microbiol. (2011) 2:150. doi: 10.3389/fmicb.2011.00150, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Fernandes MR, Sellera FP, Moura Q, Carvalho MPN, Rosato PN, Cerdeira L, et al. Zooanthroponotic transmission of drug-resistant Pseudomonas aeruginosa, Brazil. Emerg Infect Dis. (2018) 24:1160–2. doi: 10.3201/eid2406.180335, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bassiouny M, Brangsch H, Stamm I, Kopp PA, Neubauer H, Sprague LD. Comprehensive genomic analysis of multidrug-resistant Pseudomonas aeruginosa isolates from companion animals in Germany. Front Microbiol. (2026) 17:1754860. doi: 10.3389/fmicb.2026.1754860, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Benmazouz I, Kövér L, Kardos G. The rise of antimicrobial resistance in wild birds: potential AMR sources and wild birds as AMR reservoirs and disseminators: literature review. Magy Allatorv Lapja. (2024) 146:91–105. doi: 10.56385/magyallorv.2024.02.91-105 [DOI] [Google Scholar]
- 48.Kerek Á, Szabó Á, Bányai K, Kaszab E, Bali K, Papp M, et al. Resistome analysis of Escherichia coli isolates from layers in Hungary. Acta Vet Hung. (2024) 72:1–10. doi: 10.1556/004.2024.00988, [DOI] [PubMed] [Google Scholar]
- 49.Mihailovskaya VS, Erjavec MS, Kuznetsova MV. Escherichia coli from healthy farm animals: antimicrobial resistance, resistance genes and mobile genetic elements. Acta Vet Hung. (2024) 72:225–34. doi: 10.1556/004.2024.01102, [DOI] [PubMed] [Google Scholar]
- 50.Garcias B, Batalla M, Vidal A, Durán I, Darwich L. Trends in antimicrobial resistance of canine otitis pathogens in the Iberian Peninsula (2010–2021). Antibiotics. (2025) 14:328. doi: 10.3390/antibiotics14040328, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Muloi DM, Jauneikaite E, Anjum MF, Essack SY, Singleton DA, Kasudi MR, et al. Exploiting genomics for antimicrobial resistance surveillance at one health interfaces. The Lancet Microbe. (2023) 4:e1056–62. doi: 10.1016/S2666-5247(23)00284-7, [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.
